Choosing Topical Corticosteroids

Looking for:

elocon_cream 

Click here

Also what to note is whether the rash affects a small area in the face or spreads across a large area. Facial rashes can be caused by a number of conditions that range from mild to extremely serious. This article will help you identify the possible causes of rashes on face as well as become educated on available treatment for the condition. Mometasone furoate is used in the treatment of inflammatory skin disorders , allergic rhinitis , asthma for patients unresponsive to less potent corticosteroids, and penile phimosis.

Many patients complain of the scalp itching with dandruff, and because they think that the scale arises from dry skin, they decrease the frequency of shampooing, which allows further scale accumulation. They have good lubricating qualities, and their ability to vanish into the skin makes them cosmetically appealing. Creams are generally less potent than ointments of the same medication, and they often contain preservatives, which can cause irritation, stinging, and allergic reaction. Acute exudative inflammation responds well to creams because of their drying effects. Creams are also useful in intertriginous areas where ointments may not be used. However, creams do not provide the occlusive effects that ointments provide.

Facial and trunk seborrhea is characterized by powdery or greasy scale in skin folds and along hair margins. Topical steroids can also induce rosacea, which may include the eruption of erythema, papules, and pustules. Steroid-induced rosacea occurs when a facial rash is treated with low-potency topical steroids that produce resolution of the lesions. If the symptoms recur and steroid potency is gradually increased, the rosacea may become refractory to further treatment, making it necessary to discontinue the steroid. This may then induce a severe rebound erythema and pustule outbreak, which may be treated with a 10-day course of tetracycline or erythromycin .

About 20% of people with Crohn's disease also have a family member with the disease. Researchers believe that certain factors may play a role in causing UC. Both Crohn's disease and ulcerative colitis are a type of inflammatory bowel disease, or IBD. Symptoms unique to Crohn’s disease include anemia and skin changes. Symptoms of unique to ulcerative colitis include, certain rashes, an urgency to defecate .

Treatment varies depending upon the type of eczema the person has. There is no evidence of safe and effective use of topical corticosteroids in pregnant mothers. Long term use and large applications of topical corticosteroids may cause birth defects in the unborn.

One should consider referral to a dermatologist for patients with severe seborrhea in whom treatment with oral isotretinoin is contemplated, particularly if long-term therapy will likely be required. Topical corticosteroids are one of the oldest and most useful treatments for dermatologic conditions. There are many topical steroids available, and they differ in potency and formulation. Successful treatment depends on an accurate diagnosis and consideration of the steroid’s delivery vehicle, potency, frequency of application, duration of treatment, and side effects. Evidence is limited for use in melasma, chronic idiopathic urticaria, and alopecia areata.

When used as directed by your healthcare provider, topical steroids are a safe and effective way to treat conditions such as eczema, psoriasis, and atopic dermatitis. While topical steroids require a prescription from a health care provider, there are over-the-counter treatment options that may help reduce the symptoms you are experiencing. If you think you are experiencing withdrawal symptoms, talk to your healthcare provider. It's possible to mistake eczema or other skin conditions for topical steroid withdrawal, so it's important to get a proper diagnosis and start an alternative treatment if appropriate. Drugs known as calcineurin inhibitors such as tacrolimus and pimecrolimus have less use in plaque-type psoriasis than they do with eczema but are sometimes effective on the face or occluded areas. Patients who are using one or more of the systemic agents discussed below will often still require some use of topical corticosteroids for resistant areas and "hot spots."